Eve goes on sale, the first self-balancing personal exoskeleton

Wandercraft began selling Eve in the United States on 17 September 2026, at an event held with the United Spinal Association in New York. The FDA cleared the device on 11 August for adults with spinal cord injuries at any neurological level; this is the day it became something a person can actually buy.

Eve balances itself, which is what separates it from the exoskeletons that came before it. The wearer does not hold crutches or a walker, so the hands are free while standing and walking.

The commercial arrangements are the substance of this announcement. Distribution runs through National Seating & Mobility, which has more than 180 locations, through Good Shepherd Rehabilitation in Pennsylvania, and through USVetServ for Department of Veterans Affairs facilities. Wandercraft names Medicare coverage under HCPCS code K1007, VA provision and workers-compensation programmes as pathways available now — earlier, at clearance, the company had described Medicare eligibility as 60 to 90 days away.

The clinical evidence behind it remains small. A study in the Journal of Visualized Experiments followed 16 participants at the Kessler Foundation and the James J. Peters VA Medical Center; all met the mobility goals, 15 of 16 met the donning goal after four sessions, and no serious adverse events were recorded.